INTRA CELLULAR THERAPIES INC stock forecast: up to 47.19 USD ITCI stock price prognosis

STOCK

Forecast for Tue 23 May 2023 price 47.12

INTRA CELLULAR THERAPIES INC stock price forecast for further price development up to 0.98% (time horizon: 1 day) and price target of 47.19 USD. Short-term (time horizon: 2 weeks) INTRA CELLULAR THERAPIES INC share price prediction for 2023-05-23 with daily closed price projections

Key Facts

Symbol ITCI 

ISIN US46116X1019 

CUSIP 46116X101

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

Finance numbers

Revenue 37,606,000.0

Earnings per share -3.15

twitter facebook

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 56.42/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is under book price value.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - VOYA INVESTMENT MANAGEMENT LLC 2022-09-30 135102
FIRST HAWAIIAN BANK 2022-09-30 7199
Versant Capital Management, Inc 2022-09-30 14
MASSMUTUAL TRUST CO FSB/ADV 2022-12-31 43
UMB Bank, n.a. 2022-12-31 4656

Fund ownership list is based on filling form information

Fund name Date Amount Profile
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC 2022-12-31 2631 Long
JNL Series Trust 2022-12-31 57060 Long
JNL Series Trust 2022-12-31 180866 Long
JNL Series Trust 2022-12-31 11627 Long
JNL Series Trust 2022-12-31 1659 Long

Insider trading for INTRA CELLULAR THERAPIES INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1585697 Hineline Lawrence J. 2023-03-10 SALE Accept Accept Accept Accept
1756211 Neumann Mark 2023-03-10 SALE Accept Accept Accept Accept
1521548 Halstead Michael 2023-03-10 SALE Accept Accept Accept Accept
1829958 Durgam Suresh K. 2023-03-13 SALE Accept Accept Accept Accept
1585699 Mates Sharon 2023-03-10 SALE Accept Accept Accept Accept
Assets / Liabilities

Bollinger Bollinger Bands for INTRA CELLULAR THERAPIES INC can provide the information where the market is moving based on price information.

INTRA CELLULAR THERAPIES INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns INTRA CELLULAR THERAPIES INC.

On-Balance Volume information for INTRA CELLULAR THERAPIES INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for INTRA CELLULAR THERAPIES INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for INTRA CELLULAR THERAPIES INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for INTRA CELLULAR THERAPIES INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for INTRA CELLULAR THERAPIES INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for INTRA CELLULAR THERAPIES INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for INTRA CELLULAR THERAPIES INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares

Trend:
chart
FREQUENCY THERAPEUTICS INC

Trend:
chart
Evelo Biosciences

Trend:
chart
ORAGENICS INC

Trend:
chart
MINERVA NEUROSCIENCES INC

INTRA CELLULAR THERAPIES INC on Nasdaq

INTRA CELLULAR THERAPIES INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-05-12 47.19 2023-03-28 03:44
2023-04-27 47.07 2023-03-28 03:44
2023-04-28 47.08 2023-03-28 03:44
2023-05-01 47.11 2023-03-28 03:44
2023-05-02 47.11 2023-03-28 03:44
2023-05-08 47.19 2023-03-28 03:44
2023-05-09 47.18 2023-03-28 03:44
2023-05-10 47.19 2023-03-28 03:44
2023-05-03 47.15 2023-03-28 03:44
2023-05-04 47.16 2023-03-28 03:44
2023-05-05 47.16 2023-03-28 03:44
2023-05-11 47.19 2023-03-28 03:44
2023-05-15 47.18 2023-03-28 03:44
2023-05-16 47.17 2023-03-28 03:44
2023-05-17 47.16 2023-03-28 03:44
2023-05-18 47.15 2023-03-28 03:44
2023-05-19 47.14 2023-03-28 03:44
2023-05-22 47.13 2023-03-28 03:44
2023-05-23 47.12 2023-03-28 03:44
2023-03-29 47.68 2023-03-28 03:44
2023-03-30 47.89 2023-03-28 03:44
2023-03-31 47.72 2023-03-28 03:44
2023-04-03 47.91 2023-03-28 03:44
2023-04-04 47.89 2023-03-28 03:44
2023-04-05 47.93 2023-03-28 03:44
2023-04-06 47.80 2023-03-28 03:44
2023-04-13 47.36 2023-03-28 03:44
2023-04-14 47.25 2023-03-28 03:44
2023-04-07 47.69 2023-03-28 03:44
2023-04-10 47.73 2023-03-28 03:44
2023-04-11 47.45 2023-03-28 03:44
2023-04-12 47.53 2023-03-28 03:44
2023-04-17 47.19 2023-03-28 03:44
2023-04-18 47.17 2023-03-28 03:44
2023-04-19 47.10 2023-03-28 03:44
2023-04-20 47.08 2023-03-28 03:44
2023-04-21 47.05 2023-03-28 03:44
2023-04-24 47.00 2023-03-28 03:44
2023-04-25 47.04 2023-03-28 03:44
2023-04-26 47.04 2023-03-28 03:44

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.